Japanese drugmaker Takeda (TSE: 4502) posted revenue of 4.58 trillion yen ($31.7 billion) for the fiscal year ended March 31, ...

As the US government, under President Donald Trump, is on the verge of announcing significant new tariffs on pharmaceutical ...

UK-based specialty pharma business Kelso Pharma has appointed Bee Koen Low as its first chief operating officer (COO).

Privately-held Italian firm Sibylla Biotech today announced the appointment of Dieter Weinand as chairman of its board of ...

The American medicines regulator will convene its vaccine advisory committee on May 22 to weigh in on which strains should be ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) yesterday approved Tepezza (teprotumumab (Tepezza). This ...

US antivirals giant Gilead Sciences (Nasdaq: GILD) yesterday announced a substantial investment plan, noting that it is ...

Pharmaceutical and Research Manufacturers of America (PhRMA) yesterday submitted comments to the US Department of Commerce on ...

Japanese drugmaker Shionogi (TYO: 4507) is to scale up its pipeline and global ambitions with a deal worth more than $1 ...

Israel’s Teva Pharmaceutical Industries (NYSE and TASE: TEVA) today reported results for the quarter ended March 31, 2025.

US pharma major Bristol Myers Squibb is planning a massive $40 billion investment in the country over the next five years.